A5027028531- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Blood Pressure and Hypertension Studies
- Diabetes Treatment and Management
- Central Venous Catheters and Hemodialysis
- Vascular Procedures and Complications
- Chronic Disease Management Strategies
- Renal Diseases and Glomerulopathies
- Healthcare cost, quality, practices
- Healthcare Policy and Management
- Health Systems, Economic Evaluations, Quality of Life
- Vascular anomalies and interventions
- Renal and Vascular Pathologies
- Renal Transplantation Outcomes and Treatments
- Organ Donation and Transplantation
- Erythropoietin and Anemia Treatment
- Acute Kidney Injury Research
- Diet and metabolism studies
- Heart Failure Treatment and Management
- Diabetes Management and Research
- Machine Learning in Healthcare
- Clinical practice guidelines implementation
- Primary Care and Health Outcomes
- Birth, Development, and Health
- HIV/AIDS drug development and treatment
National Kidney Foundation
2015-2025
Mount Sinai Hospital
2001-2025
Sinai Hospital
2025
Icahn School of Medicine at Mount Sinai
2015-2024
University at Buffalo, State University of New York
2011-2016
Mount Sinai Medical Center
2001-2013
Johns Hopkins University
1996-2011
University of Maryland, Baltimore
2008
New York Proton Center
2004
NYU Langone Health
2001-2002
Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular all-cause mortality. Unlike other chronic diseases with established strategies for screening, there has been no consensus on whether health systems governments should prioritize early identification intervention CKD. Guidelines evaluating managing CKD are available but have not universally adopted in the absence of incentives or quality measures prioritizing care. The burden falls disproportionately...
Recognizing that race is a social and not biological construct, healthcare professionals the public have called for removal of in clinical algorithms. In response, National Kidney Foundation American Society Nephrology created Task Force on Reassessing Inclusion Race Diagnosing Diseases to examine issue provide recommendations. The final report from recommends calculating estimated glomerular filtration rate (eGFR) without coefficient using recently published CKD-EPI 2021 creatinine (cr)...
Individuals with kidney failure undergoing maintenance dialysis frequently report a high symptom burden that can interfere functioning and diminish life satisfaction. Until recently, the focus of nephrology care for patients has been related primarily to numerical targets laboratory measures, outcomes such as cardiovascular disease mortality. Routine assessment is not universal or standardized in care. Even when symptoms are identified, treatment options limited initiated infrequently, part...
This US, multicenter, observational study assessed the CKD prevalence in adult patients with type-2 diabetes mellitus (T2DM) and characterized proportion of detected undiagnosed primary care setting using following: a clinician survey; patient physical exam medical history; single blood draw for estimated glomerular filtration rate (eGFR) glycosolated hemoglobin (HbA1c); urine dipstick protein; albumin-creatinine ratio (ACR); two quality life questionnaires; 15-month record review. The...
Abstract Aim Predicting progression in diabetic kidney disease (DKD) is critical to improving outcomes. We sought develop/validate a machine-learned, prognostic risk score (KidneyIntelX™) combining electronic health records (EHR) and biomarkers. Methods This an observational cohort study of patients with prevalent DKD/banked plasma from two EHR-linked biobanks. A random forest model was trained, performance (AUC, positive negative predictive values [PPV/NPV], net reclassification index...
Clinical guidelines for people with diabetes recommend chronic kidney disease (CKD) testing at least annually using estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (uACR). We aimed to understand CKD among type 2 in the U.S.Electronic health record data were analyzed from 513,165 adults receiving primary care 24 organizations 1,164 clinical practice sites. assessed percentage of patients both one or more eGFRs uACRs each test individually 1, 2, 3 years...
ABSTRACT Importance Preliminary reports indicate that acute kidney injury (AKI) is common in coronavirus disease (COVID)-19 patients and associated with worse outcomes. AKI hospitalized COVID-19 the United States not well-described. Objective To provide information about frequency, outcomes recovery dialysis patients. Design Observational, retrospective study. Setting Admitted to hospital between February 27 April 15, 2020. Participants P atients aged ≥18 years laboratory confirmed Exposures...
An estimated 37 million Americans have chronic kidney disease (CKD). Nearly 90% do not know about their condition because of low awareness the importance CKD testing and diagnosis among practitioners people at risk for CKD. This study uses data from a national clinical laboratory to identify guideline-recommended rates across U.S.
Background Given the high prevalence of chronic kidney disease (CKD), primary care physicians (PCPs) frequently manage early stage CKD. Nonetheless, there are challenges in providing optimal CKD setting. This study sought to understand PCPs' perceptions barriers and facilitators management Study design Mixed methods Settings participants Community-based PCPs four US cities: Baltimore, MD; St. Louis, MO; Raleigh, NC San Francisco, CA. Methodology We used a self-administered questionnaire...